Hepatitis delta virus
暂无分享,去创建一个
[1] M. Manns,et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. , 2011, The New England journal of medicine.
[2] M. Levrero,et al. Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. , 2010, European journal of public health.
[3] M. Buti,et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. , 2010, Journal of hepatology.
[4] Hsei-Wei Wang,et al. Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus. , 2010, The Journal of general virology.
[5] M. Manns,et al. Establishment of a Novel Quantitative Hepatitis D Virus (HDV) RNA Assay Using the Cobas TaqMan Platform To Study HDV RNA Kinetics , 2010, Journal of Clinical Microbiology.
[6] Johnm . Taylor,et al. Origin of hepatitis delta virus. , 2010, Future microbiology.
[7] M. Manns,et al. Quantitative HBsAg and HDV‐RNA levels in chronic delta hepatitis , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[8] B. McMahon,et al. Hepatitis D outbreak among children in a hepatitis B hyper‐endemic settlement in Greenland , 2010, Journal of viral hepatitis.
[9] Z. Abbas,et al. Hepatitis D: Scenario in the Asia-Pacific region. , 2010, World journal of gastroenterology.
[10] M. Desvarieux,et al. Longitudinal evaluation of viral interactions in treated HIV‐hepatitis B co‐infected patients with additional hepatitis C and D virus , 2010, Journal of viral hepatitis.
[11] Y. Ni,et al. Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction , 2009, Journal of Virology.
[12] H. Tillmann,et al. Virological and clinical characteristics of delta hepatitis in Central Europe , 2009, Journal of viral hepatitis.
[13] S. Nwokediuko,et al. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases. , 2009, Nigerian journal of clinical practice.
[14] Pei‐Jer Chen,et al. Phosphorylation of Serine 177 of the Small Hepatitis Delta Antigen Regulates Viral Antigenomic RNA Replication by Interacting with the Processive RNA Polymerase II , 2009, Journal of Virology.
[15] M. Lai,et al. Modification of Small Hepatitis Delta Virus Antigen by SUMO Protein , 2009, Journal of Virology.
[16] D. Hober,et al. Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. , 2009, The Journal of general virology.
[17] C. Chien,et al. Clathrin-Mediated Post-Golgi Membrane Trafficking in the Morphogenesis of Hepatitis Delta Virus , 2009, Journal of Virology.
[18] Z. Abbas,et al. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. , 2009, JPMA. The Journal of the Pakistan Medical Association.
[19] C. Sureau,et al. A Function Essential to Viral Entry Underlies the Hepatitis B Virus “a” Determinant , 2009, Journal of Virology.
[20] S. Farhang,et al. The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? , 2009, Tropical doctor.
[21] Mulyanto,et al. A nationwide molecular epidemiological study on hepatitis B virus in Indonesia: identification of two novel subgenotypes, B8 and C7 , 2009, Archives of Virology.
[22] R. Diaz,et al. Influence of hepatitis B virus (HBV) genotype on the clinical course of disease in patients coinfected with HBV and hepatitis delta virus. , 2009, The Journal of infectious diseases.
[23] M. Kazanji,et al. Prevalence and Molecular Diversity of Hepatitis B Virus and Hepatitis Delta Virus in Urban and Rural Populations in Northern Gabon in Central Africa , 2009, Journal of Clinical Microbiology.
[24] M. Rizzetto. Hepatitis D: thirty years after. , 2009, Journal of hepatology.
[25] M. Colombo,et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. , 2009, Gastroenterology.
[26] M. Pelchat,et al. The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. , 2009, Virology.
[27] S. Lo,et al. The C-terminal sequence of the large hepatitis delta antigen is variable but retains the ability to bind clathrin , 2009, Virology Journal.
[28] M. Rizzetto,et al. Ribavirin treatment for chronic hepatitis D: a pilot study. , 2008, Liver.
[29] Y. Tsay,et al. ERK1/2-Mediated Phosphorylation of Small Hepatitis Delta Antigen at Serine 177 Enhances Hepatitis Delta Virus Antigenomic RNA Replication , 2008, Journal of Virology.
[30] C. Yurdaydın,et al. Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon , 2008, Journal of viral hepatitis.
[31] C. Yurdaydın,et al. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta‐analysis , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[32] M. Hussain,et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London , 2008, Journal of medical virology.
[33] M. Sugiyama,et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan , 2008, Journal of medical virology.
[34] C. Toro,et al. Does Treatment of Hepatitis B virus (HBV) Infection Reduce Hepatitis Delta virus (HDV) Replication in HIV-HBV-HDV-Coinfected Patients? , 2008, Antiviral therapy.
[35] Yi‐Hsiang Huang,et al. Hepatitis B Surface Antigen Levels and Sequences of Natural Hepatitis B Virus Variants Influence the Assembly and Secretion of Hepatitis D Virus , 2007, Journal of Virology.
[36] G. Dore,et al. Highly endemic hepatitis B infection in rural Vietnam , 2007, Journal of gastroenterology and hepatology.
[37] C. Yurdaydın,et al. A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis , 2007, Journal of viral hepatitis.
[38] A. Mele,et al. Hepatitis delta in Europe: Vanishing or refreshing? , 2007, Hepatology.
[39] C. Sureau,et al. Entry of Hepatitis Delta Virus Requires the Conserved Cysteine Residues of the Hepatitis B Virus Envelope Protein Antigenic Loop and Is Blocked by Inhibitors of Thiol-Disulfide Exchange , 2007, Journal of Virology.
[40] C. Sureau,et al. Myristoylation signal transfer from the large to the middle or the small HBV envelope protein leads to a loss of HDV particles infectivity. , 2007, Virology.
[41] M. Manns,et al. Hepatitis D virus infection—Not a vanishing disease in Europe! , 2007, Hepatology.
[42] M. Manns,et al. [27] DIFFERENTIAL CYTOKINE PATTERN OF HDV-SPECIFIC CELLULAR IMMUNE RESPONSES DISTINGUISHES TREATMENT RESPONDER AND NONRESPONDER TO PEG-IFNa-2a TREATMENT: RESULTS FROM THE HEP-NET/INTERNATIONAL HIDIT-1 STUDY , 2007 .
[43] M. Manns,et al. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration. , 2007, Journal of hepatology.
[44] I. Yu,et al. Large Hepatitis Delta Antigen Is a Novel Clathrin Adaptor-Like Protein , 2007, Journal of Virology.
[45] Andrej Lupták,et al. A Genomewide Search for Ribozymes Reveals an HDV-Like Sequence in the Human CPEB3 Gene , 2006, Science.
[46] C. Trépo,et al. HDV genotypes in the Western Brazilian Amazon region: A preliminary report. , 2006, The American journal of tropical medicine and hygiene.
[47] A. Andriulli,et al. Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta , 2006, Hepatology.
[48] D. Häussinger,et al. Treatment of chronic hepatitis delta with pegylated interferon‐α2b , 2006 .
[49] P. Marcellin,et al. Efficacy of peginterferon alpha‐2b in chronic hepatitis delta: Relevance of quantitative RT‐PCR for follow‐up , 2006, Hepatology.
[50] J. Trinchet,et al. Eighth Major Clade for Hepatitis Delta Virus , 2006, Emerging infectious diseases.
[51] C. Yurdaydın,et al. Cytotoxic CD4+ T cells in viral hepatitis , 2006, Journal of viral hepatitis.
[52] M. Lai,et al. RNA-Templated Replication of Hepatitis Delta Virus: Genomic and Antigenomic RNAs Associate with Different Nuclear Bodies , 2006, Journal of Virology.
[53] Shou-Dong Lee,et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. , 2006, Gastroenterology.
[54] T. Nishizawa,et al. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia , 2006, Journal of medical virology.
[55] J. Koskinas,et al. Quantitative Analysis of Hepatitis D Virus RNA and Hepatitis B Surface Antigen Serum Levels in Chronic Delta Hepatitis Improves Treatment Monitoring , 2006, Antiviral therapy.
[56] M. Schnölzer,et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site , 2006, Hepatology.
[57] N. Sut,et al. Efficacy of interferon α‐2b and lamivudine combination treatment in comparison to interferon α‐2b alone in chronic delta hepatitis: A randomized trial , 2006 .
[58] P. Pontisso,et al. Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus–coinfected patients , 2006, Hepatology.
[59] T. Nishizawa,et al. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia , 2005, Journal of medical virology.
[60] B. Das,et al. Seroprevalence of hepatitis D virus in patients with hepatitis B virus-related liver diseases. , 2005, The Indian journal of medical research.
[61] M. Manns,et al. Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study , 2005, Alimentary pharmacology & therapeutics.
[62] U. Akarca,et al. Two-Year Interferon Therapy with Or without Ribavirin in Chronic Delta Hepatitis , 2005, Antiviral therapy.
[63] R. Lanford,et al. Mapping of the Hepatitis B Virus Pre-S1 Domain Involved in Receptor Recognition , 2005, Journal of Virology.
[64] M. Lai. RNA Replication without RNA-Dependent RNA Polymerase: Surprises from Hepatitis Delta Virus , 2005, Journal of Virology.
[65] S. Urban,et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. , 2005, Gastroenterology.
[66] H. Netter,et al. Failure of the Lamivudine-Resistant rtM204I Hepatitis B Virus Mutants To Efficiently Support Hepatitis Delta Virus Secretion , 2005, Journal of Virology.
[67] C. Alloui,et al. Quantification of Hepatitis Delta Virus RNA in Serum by Consensus Real-Time PCR Indicates Different Patterns of Virological Response to Interferon Therapy in Chronically Infected Patients , 2005, Journal of Clinical Microbiology.
[68] K. Demır,et al. Alpha Interferon and Ribavirin Combination Therapy of Chronic Hepatitis D , 2005, Antimicrobial Agents and Chemotherapy.
[69] S. Urban,et al. Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2005 .
[70] M. Lai,et al. Hepatitis Delta Virus Antigen Is Methylated at Arginine Residues, and Methylation Regulates Subcellular Localization and RNA Replication , 2004, Journal of Virology.
[71] Yi‐Hsiang Huang,et al. Identification of novel HLA-A*0201-restricted CD8+ T-cell epitopes on hepatitis delta virus. , 2004, The Journal of general virology.
[72] M. Milinkovitch,et al. Molecular Phylogenetic Analyses Indicate a Wide and Ancient Radiation of African Hepatitis Delta Virus, Suggesting a Deltavirus Genus of at Least Seven Major Clades , 2004, Journal of Virology.
[73] N. Enomoto,et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. , 2003, The Journal of general virology.
[74] Ping Liu,et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. , 2003, The Journal of clinical investigation.
[75] M. Manns,et al. Analysis and function of delta-hepatitis virus-specific cellular immune responses , 2003 .
[76] J. Casey,et al. Inhibition of Hepatitis Delta Virus RNA Editing by Short Inhibitory RNA-Mediated Knockdown of ADAR1 but Not ADAR2 Expression , 2002, Journal of Virology.
[77] M. Manns,et al. Famciclovir treatment of chronic delta hepatitis. , 2002, Journal of hepatology.
[78] Jinhong Chang,et al. Parameters of Human Hepatitis Delta Virus Genome Replication: the Quantity, Quality, and Intracellular Distribution of Viral Proteins and RNA , 2002, Journal of Virology.
[79] S. Hsu,et al. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications , 2002, Hepatology.
[80] S. Semenov,et al. Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. , 2001, The Journal of general virology.
[81] S. Hadler,et al. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. , 2001, The Journal of general virology.
[82] M. Garrubba,et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. , 2001, Liver.
[83] K. Yano,et al. Stimulation of RNA Polymerase II Elongation by Hepatitis Delta Antigen , 2001, Science.
[84] C. Bréchot,et al. Inhibition of Hepatitis B Virus Replication by the Interferon-Inducible MxA Protein , 2001, Journal of Virology.
[85] R. D. de Man,et al. Lamivudine–high dose interferon combination therapy for chronic hepatitis B patients co‐infected with the hepatitis D virus , 2000 .
[86] S. Hsu,et al. Immunohistochemical differentiation of hepatitis D virus genotypes , 2000, Hepatology.
[87] E. Sagnelli,et al. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis , 2000, Hepatology.
[88] E. Sagnelli,et al. Chronic hepatitis D: A vanishing disease? An Italian multicenter study , 2000, Hepatology.
[89] A. Kidd,et al. Recent High Incidence of Fulminant Hepatitis in Samara, Russia: Molecular Analysis of Prevailing Hepatitis B and D Virus Strains , 2000, Journal of Clinical Microbiology.
[90] K. Russell,et al. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. , 2000, The American journal of tropical medicine and hygiene.
[91] E. Christensen,et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B , 2000, Gut.
[92] Charlotte.,et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections , 2000, Journal of viral hepatitis.
[93] J. Hoofnagle,et al. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. , 1999, Gastroenterology.
[94] J. Hoofnagle,et al. Lamivudine for chronic delta hepatitis , 1999, Hepatology.
[95] H. Hotta,et al. Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan , 1999, Journal of medical virology.
[96] O. Ciccarelli,et al. Liver transplantation and HBsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis. , 1999, Journal of hepatology.
[97] R. Purcell,et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope , 1998, Hepatology.
[98] T. Chiang,et al. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. , 1998, The Journal of general virology.
[99] F. Chang,et al. Decreasing hepatitis D virus infection in Taiwan: An analysis of contributory factors , 1997, Journal of gastroenterology and hepatology.
[100] J. Hoofnagle,et al. Geographic distribution and genetic variability of hepatitis delta virus genotype I. , 1997, Virology.
[101] A. Andriulli,et al. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients , 1997, Hepatology.
[102] M. Houghton,et al. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles , 1997, Journal of virology.
[103] K. Hyams,et al. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. , 1996, The Journal of infectious diseases.
[104] F. Callea,et al. Long‐term interferon‐α treatment of children with chronic hepatitis delta: a multicentre study , 1996 .
[105] Wen-Hsiung Li,et al. Substitution rates in hepatitis delta virus , 1995, Journal of Molecular Evolution.
[106] K. Choo,et al. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome , 1995, Hepatology.
[107] L. Rodrigo,et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. , 1995, The American journal of gastroenterology.
[108] K. Choo,et al. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D , 1995, The Lancet.
[109] F. Kinjo,et al. Seroepidemiological study of hepatitis delta virus infection in Okinawa, Japan , 1995, Journal of medical virology.
[110] W. Sheng,et al. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. , 1995, Gastroenterology.
[111] D. Mathieu,et al. Long‐term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis , 1995, Hepatology.
[112] F. Chisari,et al. Expression of the hepatitis delta virus large and small antigens in transgenic mice , 1994, Journal of virology.
[113] Shin C. Chang,et al. Mutational analysis of delta antigen: effect on assembly and replication of hepatitis delta virus , 1994, Journal of virology.
[114] J. Casey,et al. A genotype of hepatitis D virus that occurs in northern South America. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[115] J. Glenn,et al. Identification of a prenylation site in delta virus large antigen. , 1992, Science.
[116] J. Witte,et al. Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States. , 1992, JAMA.
[117] G. Alexander,et al. Hepatitis B and delta virus infection among "at risk" populations in south east London. , 1992, Journal of epidemiology and community health.
[118] M. Lai,et al. Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex , 1992, Journal of virology.
[119] P. Chen,et al. Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles , 1991, Journal of virology.
[120] F. Imazeki,et al. Heterogeneity and evolution rates of delta virus RNA sequences , 1990, Journal of virology.
[121] M. Rizzetto,et al. Hepatitis delta virus as a global health problem. , 1990, Vaccine.
[122] R Williams,et al. Early indicators of prognosis in fulminant hepatic failure. , 1989, Gastroenterology.
[123] M. Lai,et al. Human hepatitis delta virus RNA subfragments contain an autocleavage activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[124] B. J. Benenfeld,et al. An ultraviolet-sensitive RNA structural element in a viroid-like domain of the hepatitis delta virus. , 1989, Science.
[125] M. Houghton,et al. A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta , 1988, Journal of virology.
[126] G. Fattovich,et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. , 1987, The Journal of infectious diseases.
[127] M. Rizzetto,et al. A histological study of hepatitis delta virus liver disease , 1986, Hepatology.
[128] H. Schellekens,et al. The hepatitis delta (δ) virus possesses a circular RNA , 1986, Nature.
[129] Michael Houghton,et al. Structure, sequence and expression of the hepatitis delta (δ) viral genome , 1986, Nature.
[130] S. Govindarajan,et al. Fulminant B viral hepatitis: role of delta agent. , 1984, Gastroenterology.
[131] S. Hadler,et al. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. , 1984, Annals of internal medicine.
[132] N. Caporaso,et al. Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity. , 1983, Gastroenterology.
[133] M. Colombo,et al. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. , 1983, Gastroenterology.
[134] G. Kanel,et al. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. , 1983, Gastroenterology.
[135] M. Rizzetto,et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. , 1983, Annals of internal medicine.
[136] M. Rizzetto,et al. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. , 1983, American journal of epidemiology.
[137] R. Purcell,et al. delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[138] M. Rizzetto,et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. , 1977, Gut.
[139] P. Calès,et al. Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[140] J. Taylor,et al. Structure and replication of hepatitis delta virus RNA. , 2006, Current topics in microbiology and immunology.
[141] J. -. Wu,et al. Functional and clinical significance of hepatitis D virus genotype II infection. , 2006, Current topics in microbiology and immunology.
[142] P. Dény. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? , 2006, Current topics in microbiology and immunology.
[143] C. Sureau. The role of the HBV envelope proteins in the HDV replication cycle. , 2006, Current topics in microbiology and immunology.
[144] R. Purcell,et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. , 2004, Gastroenterology.
[145] P. Farci. Delta hepatitis: an update. , 2003, Journal of hepatology.
[146] E. Sagnelli,et al. Decrease in HDV endemicity in Italy. , 1997, Journal of hepatology.
[147] S. Hadziyannis. Use of α-interferon in the treatment of chronic delta hepatitis , 1991 .
[148] R. Purcell,et al. Titration of the infectivity of hepatitis D virus in chimpanzees. , 1987, The Journal of infectious diseases.
[149] M. Brunetto,et al. Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection. , 1987, Journal of hepatology.
[150] G. Actis,et al. Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy. , 1987, Digestion.
[151] C. Trépo,et al. Studies on the role of HDV in an outbreak of fulminant hepatitis in Bangui (Central African Republic). , 1987, Progress in clinical and biological research.
[152] R. Moreira,et al. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. , 2005, The American journal of tropical medicine and hygiene.